(3S)9-Methyl-3-(2,6-dimethyl-4-oxo-4H-quinazolin-3yl)-1-phenyl-6,7-dihydro-3H-[1,4]diazepino[6,7,1-hi]indol-4-one | 215104-51-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯二氮卓类
• 英文名称: (3S)9-Methyl-3-(2,6-dimethyl-4-oxo-4H-quinazolin-3yl)-1-phenyl-6,7-dihydro-3H-[1,4]diazepino[6,7,1-hi]indol-4-one
• 英文别名: (11S)-11-(2,6-dimethyl-4-oxoquinazolin-3-yl)-6-methyl-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-12-one
• CAS: 215104-51-1
• 化学式: C₂₈H₂₄N₄O₂
• 分子量: 448.524
• InChiKey: HVUUBQWZWIBQGA-SANMLTNESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  34
• 可旋转键数：
  2
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  65.3
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Pharmaceutical composition for preventing or treating a disease associated with an excess of IL-12-production
  申请人：——

  公开号：US20020119967A1

  公开（公告）日：2002-08-29

  This invention relates to the use of a PDE4 inhibitor or a pharmacologically acceptable salt thereof for manufacturing a medicament for preventing or treating a disease associated with an excess in IL-12 production.

  本发明涉及使用PDE4抑制剂或其药理学上可接受的盐来制造用于预防或治疗与IL-12过度产生相关的疾病的药物。
• Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP1188438A1

  公开（公告）日：2002-03-20

  This invention relates to the use of a PDE4 inhibitor or a pharmacologically acceptable salt thereof for manufacturing a medicament for preventing or treating a disease associated with an excess in IL-12 production.

  本发明涉及使用 PDE4 抑制剂或其药理上可接受的盐制造药物，以预防或治疗与 IL-12 生成过多有关的疾病。
• Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP1199074A1

  公开（公告）日：2002-04-24

  This invention relates to the use of a PDE4 inhibitor or a pharmacologically acceptable salt thereof for manufacturing a medicament for preventing or treating a disease associated with an excess in IL-12 production.

  本发明涉及使用 PDE4 抑制剂或其药理上可接受的盐制造药物，以预防或治疗与 IL-12 生成过多有关的疾病。
• PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES
  申请人：Pfizer Holding France

  公开号：EP0980374B1

  公开（公告）日：2003-02-12
• US6239130B1
  申请人：——

  公开号：US6239130B1

  公开（公告）日：2001-05-29